Skip to main content
Back to Valor Equity Partners

Valor Equity Partners's Biotechnology Portfolio

Browse 16 Biotechnology companies funded by Valor Equity Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
16
Total Funding in Biotechnology
$1.2B

Biotechnology Portfolio Companies (16)

Export
BiotechnologyManufacturingProduct ResearchSustainability

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Emeryville, United States
July 2024
Series D

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Los Altos, United States
July 2026
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Advanced MaterialsBioinformaticsBiotechnologyMachine LearningRobotics

Cambrium is engineering biology to create high-performance proteins.

Berlin, Germany
June 2024
Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalNeuroscienceRobotics

Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.

Fremont, United States
May 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningNeuroscience

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

New York, United States
March 2022
$6.1M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceutical

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

Exton, United States
February 2025
$75.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

AnalyticsArtificial Intelligence (AI)Big DataBiotechnologyHealth CareInformation ServicesWater

A wastewater data platform delivering population-level health insights

Cambridge, United States
June 2025
$13.4M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsLife SciencePetVeterinary

PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.

La Jolla, United States
December 2021
$62.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Chicago, United States
November 2022
$270.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyFood and BeverageFood ProcessingMachine LearningSustainability

Bettani creates plant-based ingredients and products using data-driven technology and culinary expertise.

Berkeley, United States
October 2025
$6.5M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyFood and BeverageLife ScienceManufacturing

Kingdom creates and sells natural functional ingredients that actually work.

Brooklyn, United States
October 2021
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco, United States
October 2025
$45.0M
Convertible Note

Founder Contacts

41,000+ verified contacts

BiotechnologyChemicalGreenTechManufacturing

Solugen is a carbon negative moleucle factory that replaces petroleum-based products with plant-derived substitutes.

Houston, United States
June 2024
$213.6M
Debt Financing

Founder Contacts

41,000+ verified contacts

Explore Valor Equity Partners's Full Portfolio

View all companies funded by Valor Equity Partners across every industry and funding stage.

View Full Valor Equity Partners Portfolio